CSL Behring, a Business Unit of CSL, is a global biotherapeutics leader driven by its promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease, and neurological disorders. The company’s products are also used in cardiac surgery, burn treatment and to prevent hemolytic disease of the newborn. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. The parent company, CSL Limited (ASX:CSL;USOTC:CSLLY), headquartered in Melbourne, Australia, employs more than 30,000 people, and delivers its life-saving therapies to people in more than 100 countries. For inspiring stories about the promise of biotechnology, visit CSLBehring.com/vita and follow us on Twitter.com/CSLBehring. See our community guidelines: https://bit.ly/3QZbZeZ

Website: https://www.cslbehring.com/

Employees: >10000

HQ: (610) 878-4000

Location: King Of Prussia, Pennsylvania, US

Revenue: $10.1 billion

CSL Behring is a global biotherapeutics leader specializing in the research, development, and manufacturing of life-saving medicines. With a presence in over 60 countries, the company is committed to improving the quality of life for patients around the world. If you're looking for contact information for CSL Behring, you've come to the right place. At ConnectPlex, we provide accurate and up-to-date contact information for key decision-makers and professionals in the company. Our extensive database allows you to quickly and easily connect with the right people, saving you time and resources. Whether you're looking to collaborate with CSL Behring or simply need to get in touch with someone in the company, ConnectPlex is your go-to solution. Our user-friendly platform makes it easy to search and filter through our database of millions of companies and professionals. With ConnectPlex, you can rest assured that you'll find the contact information you need quickly and efficiently. Start your search today and connect with the people who matter most to your business.

CSL Behring is a leading global biotherapeutics company that specializes in the development and delivery of innovative therapies to treat a range of medical conditions. With a focus on serving patients' needs, the company uses cutting-edge technologies to produce plasma-derived and recombinant biotherapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease, and neurological disorders. Additionally, CSL Behring's products are used in cardiac surgery, burn treatment, and to prevent hemolytic disease of the newborn. Headquartered in King of Prussia, Pennsylvania, CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma, and employs over 27,000 people worldwide. The company's products are delivered to patients in more than 100 countries, and its commitment to saving lives has inspired countless stories of hope and recovery. To learn more about the promise of biotechnology and the impact of CSL Behring's

CSL Behring is a world leader in creating life-saving treatments for serious health problems. We use the latest technology to develop and deliver therapies that help people with conditions like bleeding disorders, immune system issues, and neurological disorders. Our products also help with heart surgery, burns, and preventing a rare condition in newborns. We have a large network of plasma collection centers, and our company is based in Melbourne, Australia. We employ over 27,000 people and provide our treatments to people in over 100 countries. To learn more about how our treatments are making a difference, visit our website and follow us on social media.